Navigation Links
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Date:9/11/2007

Biotech looks forward to working closely with the FDA to help ensure that healthcare professionals have the information they need to continue to use PROCRIT safely and effectively.

About PROCRIT (Epoetin alfa)

PROCRIT can be used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients who are scheduled for elective noncardiac, nonvascular surgery. Depending on the country in which Epoetin alfa is marketed, these indications may differ.

Important U.S. Safety Information for PROCRIT

From the Boxed Warnings

* Use the lowest dose of PROCRIT that will gradually increase the

hemoglobin (Hb) concentration to the lowest level sufficient to avoid

the need for red blood cell (RBC) transfusion.

* PROCRIT and other erythropoiesis-stimulating agents (ESAs) increased the

risk for death and for serious cardiovascular events (including serious

arterial and venous thromboembolic events, myocardial infarction,

stroke, congestive heart failure) when administered to target a Hb of

greater than 12 g/dL. A rate of hemoglobin rise of greater than 1 g/dL

over 2 weeks may also contribute to these risks.

* Cancer patients: Use of ESAs:

-- Shortened the time to tumor progression in patients with advanced

head and neck cancer receiving radiation therapy when administered

to target a Hb of greater than 12 g/dL.

-- Shortened overall survival and increased deaths attributed to

disease progression at 4 months in patients with metastatic breast

cancer receiving chemotherapy when administered to target a Hb of

greater than 12 g/dL.

-- Increased the risk of death when administered to
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
6. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
7. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
8. Prana Biotechnology Presents New Key Findings on PBT2
9. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
10. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... Cornerstone Pharmaceuticals, Inc., a leader in cancer ... preclinical toxicity study of azide drug-loaded Emulsiphan nano ... under a Collaboration Agreement. Emulsiphan is Cornerstone,s proprietary ... so pleased that Cornerstone has received a report ...
... Mangrove Partners, owners of 149,373 shares representing approximately 5.71% ... CPEX ), today announced that it has ... to CPEX,s Board of Directors to be implemented through ... to shareholders at $34.73 per share, composed of a ...
Cached Medicine Technology:Cornerstone Pharmaceuticals Announces Positive Results of Emulsiphan Safety Study 2Cornerstone Pharmaceuticals Announces Positive Results of Emulsiphan Safety Study 3Mangrove Partners Proposes Fully-Financed Dividend Recapitalization to Board of CPEX Pharmaceuticals, Inc. 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 Dr. Farooq ... surgery clinic in Dubai, has announced his practice’s adoption ... is the only FDA-cleared femtosecond laser proven with more ... safety and precision of LASIK. , “We are happy ... Advanced Femtosecond Laser at our Dubai LASIK practice,” Ashraf ...
(Date:5/25/2013)... 25, 2013 Prairie Living at ... hosting an American Red Cross Blood Drive from 1:30 ... community, which is located at 955 Villa Ct. in ... those on Medicaid, who need some help to maintain ... Life," says Andrea Arview Frey, Director of Marketing for ...
(Date:5/25/2013)... 25, 2013 The current residents of Back2Basics ... and the B2B staff all came together Saturday, May 18th ... array of Indian Cuisine, the residents got up to thank ... them on their road to recovery, and giving them a ... Alcohol center in 2010 after realizing the need for a ...
(Date:5/24/2013)... Petersburg, FL (PRWEB) May 25, 2013 ... Cellulite Whisperer ® products from Sublime Beauty®. ... work to diminish cellulite, and many of the ingredients ... to deal with and is dreaded by many women," ... a concentrated holistic plan, women can diminish their cellulite." ...
(Date:5/24/2013)... ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now ... price reductions on their popular PhenObestin 37.5 non-prescription diet ... to lose weight as effortlessly as possible has reduced ... than 50%. , Bottles have been reduced from $149 ... orders will receive free shipping. , Made from ...
Breaking Medicine News(10 mins):Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2
... Incorporated,s (Nasdaq: VPHM ) third quarter financial results for ... 2009 before the open of the U.S. financial markets. , ... webcast at 9:00 a.m. Eastern Time on the same day. ... 2009 third quarter and other business. , The press ...
... BioMed Realty Trust, Inc. (NYSE: BMR ) today ... September 30, 2009 after the market closes on Wednesday, October ... Alan D. Gold, Chairman and Chief Executive Officer, and Kent ... conference call at 10:00 a.m. Pacific Time on Thursday, October ...
... Pa., Oct. 15 Pennsylvania,s commitment to children was recognized ... and mental health systems of care to the Department of ... the positive work we are doing on behalf of children ... programs and services supported by these grants, we are able ...
... , Prototype Anonymous Donor Database In Development , FAIRFAX, ... leading donor sperm providers have formed a new, non-profit ... AGDP will help donor gamete providers to share ... and activities to benefit individuals and organizations involved in ...
... Ohio, Oct. 15 The Longaberger Company is teaming up ... the fight against breast cancer. As part of the "Crucial ... clubs and players - in partnership with the American Cancer ... NFL games feature players, coaches and referees wearing pink game ...
... that the human papillomavirus vaccine might promote promiscuity, a ... the majority of respondents did not believe the HPV ... The study, conducted by University of Illinois at Chicago ... the November issue of the Journal of Adolescent ...
Cached Medicine News:Health News:ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009 2Health News:BioMed Realty Trust to Report 2009 Third Quarter Results 2Health News:Department of Public Welfare Earns Federal Recognition for Programs and Services for Children 2Health News:UIC study finds girls aware of HPV vaccine's benefits 2
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
Medicine Products: